Home meeting
 

Keywords :   


Tag: meeting

Meeting 10 Staff Presentation: Alternative Housing Options

2016-04-06 23:54:53| PortlandOnline

Includes City Councils proposed middle housing amendment, takeaways from Residential Infill Project charrette discussion, and staffs alternative housing scenario presented at SAC Meeting #10 held on April 5, 2016. PDF Document, 5,415kbCategory: Stakeholder Advisory Committee Meeting Materials

Tags: options staff alternative meeting

 

Notice to attend the Annual General Meeting of BioGaia AB

2016-04-06 17:16:34| Appliances - Topix.net

BioGaia AB will hold its Annual General Meeting at 4:00 p.m. on Tuesday, 10 May 2016, at Lundqvist & Lindqvist Klara Strand, Klarabergsviadukten 90, in Stockholm. The doors will be opened for registration at 3:30 p.m. Registration will end at 4:00 p.m. In order to participate in the Annual General Meeting , shareholders must be recorded in the register of shareholders maintained by Euroclear Sweden AB no later than Tuesday 3 May 2016 and must provide notice of participation to the company no later than Wednesday 4 May 2016.

Tags: general notice meeting annual

 
 

April 7, 2016 URM Policy Committee Meeting Agenda

2016-04-06 16:30:06| PortlandOnline

Word Document, 181kbCategory: Policy Committee

Tags: policy april meeting agenda

 

March 3, 2016 URM Policy Committee Meeting Summary

2016-04-06 16:28:04| PortlandOnline

Word Document, 176kbCategory: Policy Committee

Tags: policy march summary meeting

 

Merck to Present New Data for KEYTRUDA (pembrolizumab) at the American Association for Cancer Research 2016 Annual Meeting

2016-04-06 14:00:00| Merck.com - Research & Development News

Dateline City: KENILWORTH, N.J. Data Evaluating KEYTRUDA as a Single Agent and in Novel Combinations Across a Wide Range of Cancers to Be Presented KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new research investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in multiple tumor types, both as a single agent and in combination with other therapies, will be presented at this years American Association for Cancer Research (AACR) Annual Meeting in New Orleans, April 16 20. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Kim Hamilton, 908-740-1863orInvestor:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: data research present american

 

Sites : [444] [445] [446] [447] [448] [449] [450] [451] [452] [453] [454] [455] [456] [457] [458] [459] [460] [461] [462] [463] next »